We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Bayer Aktiengesellschaft (PK) | USOTC:BAYRY | OTCMarkets | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.15 | -1.99% | 7.37 | 7.33 | 7.42 | 7.42 | 7.33 | 7.41 | 354,669 | 21:01:07 |
From Jun 2022 to Jun 2024
By Joshua Kirby
Bayer AG said Wednesday that Chief Executive Officer Werner Baumann will step down ahead of schedule, to be replaced by Roche Holding AG executive William N. Anderson from June 1.
Mr. Anderson will join the German conglomerate's board of management on April 1, becoming CEO over a transition that will end with Mr. Baumann's retirement at the end of May, Bayer said.
"Werner Baumann will work closely with Bill Anderson to ensure a smooth transition process," the company said.
Mr. Baumann's contract had originally been set to run until April next year.
The appointment of Mr. Anderson--currently CEO of Roche Pharmaceutical--caps a search that began in the middle of last year, Bayer said.
Shares in Bayer rose 6.2% to EUR62.59 following the news.
Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby
(END) Dow Jones Newswires
February 08, 2023 11:44 ET (16:44 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Bayer Aktiengesellschaft (PK) Chart |
1 Month Bayer Aktiengesellschaft (PK) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
